Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from ColgatePalmolive

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022

Shrinkflation bites as popular Snickers bar gets downsized

Shrinkflation bites as popular Snickers bar gets downsized

A popular chocolate treat is the latest victim of 'shrinkflation' as rising costs continue to put pressure on food manufacturers.

Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2022

Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Looking Into Colgate-Palmolive's Recent Short Interest

Colgate-Palmolive's (NYSE:CL) short percent of float has fallen 5.03% since its last report. The company recently reported that it has 14.22 million shares sold short, which is 1.7% of all regular shares that are available for trading.

Golden Cross Appears Before Colgate-Palmolive Investors

If history is any guide, there may be good fortune ahead for shares of Colgate-Palmolive (NYSE:CL). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Looking Into Colgate-Palmolive's Recent Short Interest

Colgate-Palmolive's (NYSE:CL) short percent of float has risen 26.96% since its last report. The company recently reported that it has 12.25 million shares sold short, which is 1.46% of all regular shares that are available for trading.

Colgate-Palmolive's Return On Invested Capital Insights

Pulled from Benzinga Pro data, Colgate-Palmolive (NYSE:CL) posted Q1 earnings of $603.00 million, an increase from Q4 of 220.74%. Sales dropped to $4.40 billion, a 0.09% decrease between quarters.

inkl

Read news from The Economist, FT, and more,
with one subscription

Barclays Maintains Equal-Weight Rating for Colgate-Palmolive: Here's What You Need To Know

Barclays Maintains Equal-Weight Rating for Colgate-Palmolive: Here's What You Need To Know

Barclays has decided to maintain its Equal-Weight rating of Colgate-Palmolive (NYSE:CL) and lower its price target from $81.00 to $77.00. Shares of Colgate-Palmolive are trading down 0.3% over the last 24 hours, at $74.95 per share.

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022

What 7 Analyst Ratings Have To Say About Colgate-Palmolive

What 7 Analyst Ratings Have To Say About Colgate-Palmolive

Colgate-Palmolive (NYSE:CL) has observed the following analyst ratings within the last quarter:

Recap: Colgate-Palmolive Q1 Earnings

Recap: Colgate-Palmolive Q1 Earnings

Colgate-Palmolive (NYSE:CL) reported its Q1 earnings results on Friday, April 29, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Colgate-Palmolive's Earnings Outlook

Colgate-Palmolive's Earnings Outlook

Colgate-Palmolive (NYSE:CL) is set to give its latest quarterly earnings report on Friday, 2022-04-29. Here's what investors need to know before the announcement. Analysts estimate that Colgate-Palmolive will report an earnings per share (EPS) of $0.75.

Expert Ratings For Colgate-Palmolive

Expert Ratings For Colgate-Palmolive

Analysts have provided the following ratings for Colgate-Palmolive (NYSE:CL) within the last quarter:

Death Cross Looms Over Colgate-Palmolive Investors

Death Cross Looms Over Colgate-Palmolive Investors

If history is any guide, there may be trouble ahead for shares of Colgate-Palmolive (NYSE:CL). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Get all your
news in one place.

100's of premium titles.
One news app.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

SherwinWilliams

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play